Drug shortages

Methotrexate Sodium Injection

Fresenius Kabi USA, LLC · Available

Current63323-122-50Rheumatology +1
Open FDA's page for this record
Update type
Reverified
Initial posting date
03/13/2023
Package NDC
63323-122-50
Generic name
Methotrexate Sodium Injection
Contact info
888-386-1300
Availability
Available
Related info
Check wholesaler for inventory
Update date
11/03/2026
Dosage form
Injection
Presentation
Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)
Company name
Fresenius Kabi USA, LLC
Status
Current
Therapeutic category
Rheumatology, Oncology
Harmonized identifiers (openFDA)
Application number
ANDA040266
Brand name
METHOTREXATE
Generic name
METHOTREXATE SODIUM
Manufacturer name
Fresenius Kabi USA, LLC
Product NDC
63323-122
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
Substance name
METHOTREXATE SODIUM
RxCUI
311625
SPL ID
3d21237a-ef53-4592-bf06-0c739696203d
SPL set ID
ec476b11-0b3c-4139-b1eb-a3daa76bc271
Package NDC
63323-122-50
UNII
3IG1E710ZN
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.